NCT02274259View on ClinicalTrials.gov

Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

December 31, 2016

Conditions
Central Retinal Vein Occlusion
Interventions
DRUG

Aflibercept

Aflibercept injection is given at every visit. Time to next treatment according to presence of macular edema

DRUG

Ranibizumab

Ranibizumab injection is given at every visit. Time to next treatment according to presence of macular edema

Trial Locations (1)

11282

St Eriks Eye Hospital, Stockholm

All Listed Sponsors
lead

Anders Kvanta

OTHER

NCT02274259 - Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen | Biotech Hunter | Biotech Hunter